Market Cap (In TWD)
1.57 Billion
Revenue (In TWD)
4.85 Million
Net Income (In TWD)
-61.54 Million
Avg. Volume
126.77 Thousand
- Currency
- TWD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 32.05-69.9
- PE
- -
- EPS
- -
- Beta Value
- -0.014
- ISIN
- TW0007427007
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. Chia-Nan Chen
- Employee Count
- -
- Website
- https://www.gntbm.com.tw
- Ipo Date
- 2021-07-08
- Details
- Great Novel Therapeutics Biotech & Medicals engages in the development of drugs for the treatment of advanced and refractory cancers. It develops drugs for cancer immunotherapy, including tumor microenvironment regulators, epigenetic immunoactivators, and immune-regulating multi-kinase inhibitors. The company was formerly known as GNT Biotech & Medicals Corporation. Great Novel Therapeutics Biotech & Medicals was founded in 2013 and is based in Taipei City, Taiwan.
More Stocks
-
SOLSasol Limited
SOL
-
TIRUPATIFLTirupati Forge Limited
TIRUPATIFL
-
0896
-
ENKAI
-
SIS
-
BAESFBAE Systems plc
BAESF
-
NSARONSTAR Electric Company
NSARO
-
APTL